Zolmitriptan works by stimulating 5-HT₁B and 5-HT₁D receptors located on intracranial blood vessels and sensory nerves of the trigeminal system. This action leads to cranial vessel constriction and inhibition of pro-inflammatory neuropeptide release, effectively alleviating migraine symptoms such as headache, nausea, and sensitivity to light and sound